Adaptive Biotechnologies Corp (ADPT) › Capital ExpendituresAdaptive Biotechnologies Corp (ADPT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $2.42M2018: $6.30M2019: $11.20M2020: $18.80M2021: $61.75M2022: $16.35M2023: $10.70M2024: $3.66M2025: $2.96M$2.96M2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$2.96M-19.2%2024$3.66M-65.7%2023$10.70M-34.6%2022$16.35M-73.5%2021$61.75M+228.4%2020$18.80M+67.9%2019$11.20M+77.8%2018$6.30M+160.2%2017$2.42M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share